Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03723967
Title FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel (FRAIL-IMMUNE)
Acronym FRAIL-IMMUNE
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
CHU d'Amiens Amiens 80054 France Details
ICO - Centre Paul Papin Angers 59055 France Details
Institut Sainte-Catherine Avignon 84918 France Details
Centre Georges-François Leclerc Dijon 21079 France Details
Clinique des Ormeaux Le Havre 76600 France Details
Groupe hospitalier Bretagne Sud Lorient 56322 France Details
Hôpital de la Croix-Rousse Lyon 69004 France Details
Centre Léon Bérard Lyon 69008 France Details
Hôpital de la Timone Marseille 13005 France Details
ICM - Centre Val d'Aurelle Montpellier 34298 France Details
Hôpital Privé du Confluent Nantes 44277 France Details
Centre Henri Becquerel Rouen 76038 France Details
ICO - Centre René Gauducheau Saint-Herblain 44805 France Details
Clinique Mutualiste de l'Estuaire Saint-Nazaire 44600 France Details
Centre Paul Strauss Strasbourg 67065 France Details
Institut de Cancérologie de Lorraine Alexis Vautrin Vandœuvre-lès-Nancy 54511 France Details
Institut Gustave Roussy Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field